Valeant Director Ingram Says Pearson Has Board's Full SupportBy
Company was accused of fraud by short seller Citron Research
Drugmaker's stocks, bonds have plunged since report published
Robert Ingram, a director of Valeant Pharmaceuticals International Inc., said Chief Executive Officer Michael Pearson has “unanimous and strong support” from the board.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.